Coronavirus: late-stage trial of Chinese mRNA vaccine candidate to begin in Mexico

May 12, 2021 | INVESTING

A late-stage human trial of the first mRNA Covid-19 vaccine candidate developed in China – using the same technology as the Pfizer and Moderna jabs – will begin in Mexico later this month.Mexican Foreign Minister Marcelo Ebrard said in a tweet on Tuesday the phase 3 trial of the vaccine made by China’s Walvax Biotechnology would start on May 30, with 6,000 people taking part.“Chinese authorities have officially communicated to us that they will begin in Mexico pending authorisation from the…

Read More

Pin It on Pinterest